Last updated on December 2018

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer


Brief description of study

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer (TNBC).

Clinical Study Identifier: NCT03371017

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: MO39193 ...

Private Oncology Centre
Pretoria, South Africa
1.82miles
  Connect »

Reference Study ID Number: MO39193 ...

University of Pretoria Oncology Department; Medical Oncology
Pretoria, South Africa
8.37miles
  Connect »